- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Triple-negative Breast Cancer in South Africa
Total 742 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
MacroGenicsCompletedCervical Cancer | Hematologic Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Small-cell Lung Cancer | TNBC - Triple-Negative Breast Cancer | HER2-positive Advanced Solid TumorsHong Kong, United States, Thailand, Australia, Spain, Bulgaria, Poland, Ukraine
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Bayer; United States Department of Defense; Canadian...TerminatedNode Positive HER2 Negative Breast CancerUnited States, Canada, Puerto Rico, Guam
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)SuspendedInvasive Breast Carcinoma | HER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Breast Adenocarcinoma | Inflammatory Breast CarcinomaUnited States
-
City of Hope Medical CenterCompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
European Organisation for Research and Treatment...CompletedBreast CancerBelgium, Netherlands, France, Egypt, South Africa, United Kingdom, Denmark, Serbia, Poland
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast Carcinoma | Metastatic BRCA-Associated Breast CarcinomaUnited States, Puerto Rico
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Avera McKennan Hospital & University Health CenterWithdrawnMetastatic Breast Cancer | Breast Tumor | Advanced Gynecologic CancerUnited States
-
Medical Research CouncilCompletedBreast CancerUnited Kingdom, South Africa
-
National Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Eli Lilly and CompanyTerminatedBreast CancerMexico, France, Australia, Argentina, South Africa
-
Eli Lilly and CompanyCompletedBreast CancerItaly, Spain, Turkey, Germany, South Africa
-
Antiva BiosciencesCompletedCervical Cancer | Human Papilloma Virus | HSIL, High Grade Squamous Intraepithelial Lesions | Cervical Dysplasia | HSIL of Cervix | High-Grade Cervical Intraepithelial Neoplasia | HIV Negative | CIN - Cervical Intraepithelial Neoplasia | Cervical NeoplasmSouth Africa
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | OsteoporosisFrance, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Sanford HealthTerminatedMetastatic Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedBreast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor NegativeUnited States, Guam
-
Hellenic Breast Surgeons SocietyCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)SuspendedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor... and other conditionsUnited States
-
ETOP IBCSG Partners FoundationCompletedBreast CancerItaly, Switzerland, Australia, Peru, South Africa, Chile, Belgium, Brazil, Romania, Hungary, Nigeria
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
St Vincent's HospitalRecruitingHormone Receptor Positive Tumor | Early-stage Breast CancerAustralia
-
Ohio State University Comprehensive Cancer CenterRecruitingStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast CarcinomaUnited States, Puerto Rico
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
SanofiCompletedBreast CancerUnited States, France, Canada, Germany, Italy, Netherlands, Spain, Switzerland, Turkey, Belgium, Argentina, Denmark, Colombia, Korea, Republic of, South Africa
-
Medical University of South CarolinaCompletedBreast Cancer Female | Stress ReactionUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy...CompletedMetastatic Breast CancerAustralia
-
Pharmassist LtdUniversity of AthensActive, not recruiting
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Elevated CA15-3 or CEA or CA27-29United States, Puerto Rico, Guam
-
Universidad de Costa RicaUnknownMetastatic Breast Cancer | Mutation, PointCosta Rica
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdActive, not recruitingBreast Cancer | Gastric/Gastroesophageal Junction CancerUnited States
-
Olema Pharmaceuticals, Inc.PfizerRecruiting
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, Australia